BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23730936)

  • 41. Inhibitory effects of lemon grass (Cymbopogon citratus Stapf) on formation of azoxymethane-induced DNA adducts and aberrant crypt foci in the rat colon.
    Suaeyun R; Kinouchi T; Arimochi H; Vinitketkumnuen U; Ohnishi Y
    Carcinogenesis; 1997 May; 18(5):949-55. PubMed ID: 9163680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane.
    Paulsen JE; Bjørheim J; Røe J; Eide TJ; Alexander J; Gaudernack G
    Anticancer Res; 2002; 22(1A):171-5. PubMed ID: 12017282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Promising Chemoprevention of Colonic Aberrant Crypt Foci by
    Sahebi Z; Emtyazjoo M; Mostafavi PG; Bonakdar S
    Anticancer Agents Med Chem; 2020; 20(17):2041-2052. PubMed ID: 32532197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.
    Vivona AA; Shpitz B; Medline A; Bruce WR; Hay K; Ward MA; Stern HS; Gallinger S
    Carcinogenesis; 1993 Sep; 14(9):1777-81. PubMed ID: 8403199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells.
    Kouchi H; Nakamura K; Fushimi K; Sakaguchi M; Miyazaki M; Ohe T; Namba M
    Biochem Biophys Res Commun; 1999 Nov; 264(3):915-20. PubMed ID: 10544030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
    Janakiram NB; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.
    Elsheikh W; Blackler RW; Flannigan KL; Wallace JL
    Nitric Oxide; 2014 Sep; 41():131-7. PubMed ID: 24747869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation.
    Dixit D; Sharma V; Ghosh S; Koul N; Mishra PK; Sen E
    Free Radic Biol Med; 2009 Aug; 47(4):364-74. PubMed ID: 19409983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppressive effect of pioglitazone, a PPAR gamma ligand, on azoxymethane-induced colon aberrant crypt foci in KK-Ay mice.
    Ueno T; Teraoka N; Takasu S; Nakano K; Takahashi M; Yamamoto M; Fujii G; Komiya M; Yanaka A; Wakabayashi K; Mutoh M
    Asian Pac J Cancer Prev; 2012; 13(8):4067-73. PubMed ID: 23098518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats.
    Suh N; Paul S; Hao X; Simi B; Xiao H; Rimando AM; Reddy BS
    Clin Cancer Res; 2007 Jan; 13(1):350-5. PubMed ID: 17200374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockade of the Ras pathway by manumycin, a farnesyltransferase inhibitor, overcomes the resistance of myeloma plasma cells to Fas-induced apoptosis.
    Frassanito MA; Mastromauro L; Cusmai A; Dammacco F
    Clin Exp Med; 2005 Mar; 4(4):174-82. PubMed ID: 15750764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High susceptibility to azoxymethane-induced colorectal carcinogenesis in obese KK-Ay mice.
    Teraoka N; Mutoh M; Takasu S; Ueno T; Nakano K; Takahashi M; Imai T; Masuda S; Sugimura T; Wakabayashi K
    Int J Cancer; 2011 Aug; 129(3):528-35. PubMed ID: 20886595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plum polyphenols inhibit colorectal aberrant crypt foci formation in rats: potential role of the miR-143/protein kinase B/mammalian target of rapamycin axis.
    Banerjee N; Kim H; Talcott ST; Turner ND; Byrne DH; Mertens-Talcott SU
    Nutr Res; 2016 Oct; 36(10):1105-1113. PubMed ID: 27865352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats.
    Miyamoto S; Kohno H; Suzuki R; Sugie S; Murakami A; Ohigashi H; Tanaka T
    Oncol Rep; 2006 May; 15(5):1169-73. PubMed ID: 16596181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preventive Effect of an Infusion of the Aqueous Extract of Chaya Leaves (
    Kuri-García A; Godínez-Santillán RI; Mejía C; Ferriz-Martínez RA; García-Solís P; Enríquez-Vázquez A; García-Gasca T; Guzmán-Maldonado SH; Chávez-Servín JL
    J Med Food; 2019 Aug; 22(8):851-860. PubMed ID: 31074673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
    Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
    Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colon epithelial proliferation and carcinogenesis in diet-induced obesity.
    Takahashi H; Hosono K; Endo H; Nakajima A
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():41-7. PubMed ID: 24251703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect on nutritional markers of a model of aberrant crypt foci induced by azoxymethane and sodium dextran sulfate in Sprague Dawley rats.
    Kuri-García A; González-Reyes A; Aranda-Vargas PJ; Moreno Celis U; Mejía C; García-Gasca T; Ferríz-Martínez RA; de la Torre-Carbot K; Saldaña Gutiérrez C; Chávez-Servín JL
    Nutr Hosp; 2019 Oct; 36(5):1163-1170. PubMed ID: 31516013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
    Hosono K; Endo H; Takahashi H; Sugiyama M; Uchiyama T; Suzuki K; Nozaki Y; Yoneda K; Fujita K; Yoneda M; Inamori M; Tomatsu A; Chihara T; Shimpo K; Nakagama H; Nakajima A
    Mol Carcinog; 2010 Jul; 49(7):662-71. PubMed ID: 20564343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Aberrant crypt foci as biomarkers in chemoprevention for colorectal cancer].
    Katsuki S; Oui M; Takayama T; Takahashi Y; Shuichi N; Niitsu Y
    Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):379-84. PubMed ID: 9695076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.